How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Agriculture · Forecast 2027–2033
Bionematicides Professional Market
- By Product Type: Microbial Bionematicides, Biochemical Bionematicides, Plant Extract-Based Bionematicides, Organic Acid-Based Bionematicides
- By Mode of Application: Soil Treatment, Seed Treatment, Foliar Application, Irrigation System Application
- By Target Nematode Species: Root-Knot Nematodes (Meloidogyne spp.), Cyst Nematodes (Heterodera spp.), Lesion Nematodes (Pratylenchus spp.), Stubby Root Nematodes (Trichodorus spp.)
- By Crop Type: Vegetables, Fruits and Nuts, Cereals and Grains, Turf and Ornamentals, Root and Tuber Crops
- By Formulation: Wettable Powder, Granules, Liquid Concentrates, Emulsifiable Concentrates
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Microbial Bionematicides leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Bionematicides Professional Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Mode of Application 4
Target Nematode Species 4
Crop Type 5
Formulation 4
Companies profiled
Bayer AG
Syngenta AG
BASF SE
Valent BioSciences Corporation
Certis USA LLC
Nufarm Limited
UPL Limited
Koppert Biological Systems
Andermatt Biocontrol AG
Biobest Group NV
Marrone Bio Innovations Inc.
Isagro S.p.A.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bayer AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Valent BioSciences Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Certis USA LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nufarm Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →UPL Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Koppert Biological Systems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Andermatt Biocontrol AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Biobest Group NV
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Marrone Bio Innovations Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Isagro S.p.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Lallemand Plant Care
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →AgBiome
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Valent U.S.A. LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,310M by 2033 · 3.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Microbial Bionematicides42.0
- Biochemical Bionematicides22.6
- Plant Extract-Based Bionematicides23.5
- Organic Acid-Based Bionematicides11.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,837M → $2,187M · 2.2%
Europe$1,280M → $1,846M · 4.7%
Asia Pacific$1,169M → $1,701M · 4.8%
Latin America$723.6M → $933.7M · 3.2%
Middle East and Africa$556.6M → $798.3M · 4.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.412026
3.432027
3.452028
3.462029
3.472030
3.472031
3.492032
3.492033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bayer AG24.9
- Syngenta AG25.7
- BASF SE5.0
- Valent BioSciences Corporation5.4
- Certis USA LLC4.5
- Nufarm Limited6.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type20.9%
Mode of Application26.8%
Target Nematode Species8.9%
Crop Type25.8%
Formulation17.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America29.3
- Europe24.7
- Asia Pacific22.8
- Latin America12.5
- Middle East and Africa10.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bayer AG | 89 | 85 | 90 | 76 | 97 | 98 | 89 |
| Syngenta AG | 81 | 86 | 90 | 73 | 70 | 89 | 82 |
| BASF SE | 87 | 80 | 76 | 85 | 81 | 86 | 83 |
| Valent BioSciences Corporation | 77 | 61 | 59 | 68 | 65 | 70 | 67 |
| Certis USA LLC | 70 | 57 | 62 | 55 | 60 | 72 | 63 |
| Nufarm Limited | 64 | 61 | 69 | 56 | 47 | 69 | 61 |
| UPL Limited | 44 | 49 | 66 | 49 | 54 | 54 | 53 |
| Koppert Biological Systems | 41 | 60 | 35 | 40 | 52 | 47 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bayer AG
- Syngenta AG
- BASF SE
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bayer AG | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Syngenta AG | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| BASF SE | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Valent BioSciences Corporation | ✓ | ◐ | ◐ | ◐ | ◐ | − |
| Certis USA LLC | ✓ | − | − | ◐ | ◐ | ◐ |
| Nufarm Limited | ✓ | ◐ | − | − | − | ◐ |
| UPL Limited | − | ◐ | − | ◐ | − | ◐ |
| Koppert Biological Systems | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bayer AG89
2BASF SE83
3Syngenta AG82
4Valent BioSciences Corporation67
5Certis USA LLC63
6Nufarm Limited61
7UPL Limited53
8Koppert Biological Systems46
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Bayer AGSyngenta AGBASF SE
Challenger1
Strong scale, closing on the leaders.
Valent BioSciences Corporation
Contender2
Focused players with pockets of strength.
Certis USA LLCNufarm Limited
Niche2
Specialists in a single segment or region.
UPL LimitedKoppert Biological Systems
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Bionematicides Professional Market — a $322M beachhead inside a $4.97B market.
Beachhead (SOM)$322Mobtainable near-term
Serviceable (SAM)$1.75Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Microbial Bionematicides
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Biochemical Bionematicides
Strong fit — clear ROI and a fast path to value.
End user66 fit
Plant Extract-Based Bionematicides
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Mode of Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Nematode Species
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel29%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bionematicides Professional Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified23%
Evaluation12%
Closed-won8%
$15.8KCAC
$64KLTV
4.1:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Bionematicides Professional Market is a resilient opportunity — $2.52B by 2033, compounding at 6.0%.
TAM · 2025$1.59Btoday
TAM · 2033$2.52Bforecast
CAGR6.0%2027–2033
Cumulative$18.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.52BTotal addressable market
SAM$994MServiceable available market
SOM$202MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.0% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.52BLarge & growingTAM by 2033 at 6.0% CAGR
$994MServiceable nowreachable with today’s model
$202MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.97BBear3.9% CAGR
$2.52BBase6.0% CAGR
$3.23BBull7.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Mode of Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Bionematicides Professional Market — a $1.79B market by 2033. Plan: grow share from 7.6% to 14.7%.
Market size · 2033$1.79Btotal addressable
Market CAGR11.2%2027–2033
Target share14.7%from 7.6% today
Revenue ambition$264Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.6% | 14.7% | Ahead |
| Revenue | $147M | $264M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 36.3% | 40.1% | Behind |
| Customer retention | 89.1% | 93.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Mode of Application capability
A defensible second engine — invest in Mode of Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Mode of Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $27M capacity & capability investment
- Greenlight bolt-on M&A in Mode of Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Bionematicides Professional Market conversation — a $8.68B market you can size, segment and defend in minutes.
Market size · 2033$8.68Btotal opportunity
Growth8.5%CAGR to 2033
Addressable buyers1,800+accounts in scope
Typical ROI6.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.8×return on cost, year one
< 2 mopayback period
$62K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Bayer AGSyngenta AGBASF SEValent BioSciences CorporationCertis USA LLCNufarm LimitedUPL LimitedKoppert Biological Systems+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bionematicides Professional Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bionematicides Professional Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Agriculture · scroll →Sunflower Oilseed Processing Professional Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportFeather Meal Professional Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportPsyllium Seed Professional Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportSoil Treatment Professional Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportPalm and Soybean Oil Professional Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportAgriculture Equipment Professional Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportSprinkler Irrigation Systems Professional Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportPlantains Professional Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportSulfur Fertilizers Professional Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportCompound Fertilizer Professional Market
Market size, share, segmentation and regional forecast.
$461M market · 2025 base year
View reportMalted Barley Professional Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportDripline Professional Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.